Tempus AI, Inc. $TEM Shares Sold by SG Americas Securities LLC

SG Americas Securities LLC cut its holdings in Tempus AI, Inc. (NASDAQ:TEM) by 12.9% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 324,077 shares of the company’s stock after selling 47,966 shares during the period. SG Americas Securities LLC’s holdings in Tempus AI were worth $14,655,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of TEM. GC Wealth Management RIA LLC acquired a new stake in Tempus AI during the fourth quarter worth about $399,267,000. Voloridge Investment Management LLC boosted its stake in Tempus AI by 183.0% in the third quarter. Voloridge Investment Management LLC now owns 1,607,083 shares of the company’s stock valued at $129,708,000 after acquiring an additional 1,039,176 shares during the period. BNP Paribas Financial Markets grew its holdings in shares of Tempus AI by 312.7% during the third quarter. BNP Paribas Financial Markets now owns 1,274,549 shares of the company’s stock valued at $102,869,000 after purchasing an additional 965,730 shares during the last quarter. AQR Capital Management LLC bought a new position in shares of Tempus AI during the second quarter valued at approximately $54,020,000. Finally, Vanguard Group Inc. raised its position in shares of Tempus AI by 8.7% during the 4th quarter. Vanguard Group Inc. now owns 10,258,621 shares of the company’s stock worth $605,772,000 after purchasing an additional 817,014 shares during the period. Institutional investors own 24.22% of the company’s stock.

Insider Buying and Selling at Tempus AI

In other news, CFO James William Rogers sold 10,853 shares of the stock in a transaction on Tuesday, May 19th. The stock was sold at an average price of $44.07, for a total transaction of $478,291.71. Following the completion of the sale, the chief financial officer owned 126,395 shares in the company, valued at approximately $5,570,227.65. This represents a 7.91% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Eric P. Lefkofsky sold 166,250 shares of the firm’s stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $46.70, for a total value of $7,763,875.00. Following the sale, the chief executive officer directly owned 8,808,533 shares of the company’s stock, valued at approximately $411,358,491.10. This represents a 1.85% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 392,307 shares of company stock valued at $18,901,264. Corporate insiders own 24.26% of the company’s stock.

Analyst Upgrades and Downgrades

TEM has been the topic of several recent research reports. BTIG Research reissued a “buy” rating and issued a $80.00 price target on shares of Tempus AI in a report on Monday, June 1st. Wolfe Research assumed coverage on Tempus AI in a research note on Tuesday, June 2nd. They issued a “peer perform” rating on the stock. TD Cowen boosted their price target on shares of Tempus AI from $65.00 to $68.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. Morgan Stanley dropped their price objective on shares of Tempus AI from $85.00 to $70.00 and set an “overweight” rating on the stock in a report on Tuesday, March 3rd. Finally, Guggenheim cut their price objective on shares of Tempus AI from $95.00 to $60.00 and set a “buy” rating on the stock in a research report on Monday, March 30th. Nine equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $68.54.

Tempus AI Price Performance

NASDAQ:TEM opened at $54.87 on Friday. The company has a quick ratio of 3.15, a current ratio of 3.31 and a debt-to-equity ratio of 2.96. The business’s 50-day moving average price is $50.07 and its 200 day moving average price is $55.08. Tempus AI, Inc. has a 52-week low of $41.73 and a 52-week high of $104.32. The firm has a market cap of $9.85 billion, a P/E ratio of -31.90 and a beta of 3.62.

Tempus AI (NASDAQ:TEM) last issued its quarterly earnings results on Tuesday, May 5th. The company reported ($0.13) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.21) by $0.08. The company had revenue of $348.12 million during the quarter, compared to the consensus estimate of $345.44 million. Tempus AI had a negative net margin of 22.20% and a negative return on equity of 53.83%. Tempus AI’s revenue was up 36.1% on a year-over-year basis. During the same period in the prior year, the company earned ($0.24) EPS. As a group, sell-side analysts predict that Tempus AI, Inc. will post -1.35 earnings per share for the current fiscal year.

Tempus AI Profile

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.